NOT FOR REPRINT
Page Printed from: benefitspro.com/author/profile/jay-hancock-kaiser-health-news-shefali-luthra-kaiser-health-news
Sign In To follow
With federal officials seemingly unwilling or unable to come up with legislation to control skyrocketing drug prices, that task is increasingly moving to the states. But so is pharma muscle and money.